about
Emerging Role of Genomic Rearrangements in Breast Cancer: Applying Knowledge from Other CancersEpigenetic dysregulation: a novel pathway of oncogenesis in pediatric brain tumorsThe molecular biology of WHO grade I astrocytomasPilocytic astrocytoma: a disease with evolving molecular heterogeneityScreening genes crucial for pediatric pilocytic astrocytoma using weighted gene coexpression network analysis combined with methylation data analysis.A new GTF2I-BRAF fusion mediating MAPK pathway activation in pilocytic astrocytoma.Adult pilocytic astrocytomas: clinical features and molecular analysisConstitutional chromosomal events at 22q11 and 15q26 in a child with a pilocytic astrocytoma of the spinal cord.Novel drugs in pediatric gliomas.Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma.An 80-year experience with optic nerve glioma cases at the Armed Forces Institute of Pathology: evolution from museum to molecular evaluation suggests possibe interventions in the cellular senescence and microglial pathways (an American OphthalmologChromosome band 7q34 deletions resulting in KIAA1549-BRAF and FAM131B-BRAF fusions in pediatric low-grade Gliomas.The mTOR signaling pathway as a treatment target for intracranial neoplasmsThe BRAF kinase domain promotes the development of gliomas in vivo.Transcriptional network analysis reveals that AT1 and AT2 angiotensin II receptors are both involved in the regulation of genes essential for glioma progression.KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocytomas.Model-Based Evaluation of Spontaneous Tumor Regression in Pilocytic AstrocytomaComparative transcriptomics reveals similarities and differences between astrocytoma grades.BRAF Fusion Analysis in Pilocytic Astrocytomas: KIAA1549-BRAF 15-9 Fusions Are More Frequent in the Midline Than Within the CerebellumMolecular markers in pediatric neuro-oncology.MicroRNA profiling in pediatric pilocytic astrocytoma reveals biologically relevant targets, including PBX3, NFIB, and METAP2.Non-random aneuploidy specifies subgroups of pilocytic astrocytoma and correlates with older age.Clinical Neuropathology Practice News 4-2012: levels of evidence for brain tumor biomarkers.Neural stem cells secrete factors facilitating brain regeneration upon constitutive Raf-Erk activation.Pediatric Brain Tumors: Current Knowledge and Therapeutic OpportunitiesPosterior fossa and spinal gangliogliomas form two distinct clinicopathologic and molecular subgroups.A novel brain tumour model in zebrafish reveals the role of YAP activation in MAPK- and PI3K-induced malignant growth.Investigation of Targetin, a Microtubule Binding Agent which Regresses the Growth of Pediatric High and Low Grade Gliomas.Molecular markers of glioma: an update on recent progress and perspectives.Progress on molecular biomarkers and classification of malignant gliomas.Pediatric high-grade astrocytomas: a distinct neuro-oncological paradigm.Prognostic and predictive biomarkers in adult and pediatric gliomas: toward personalized treatment.The molecular landscape of pediatric brain tumors in the next-generation sequencing era.Endoscopic biopsy of brain tumors: Does the technique matter?Differential expression and methylation of brain developmental genes define location-specific subsets of pilocytic astrocytoma.The RAF-MEK-ERK pathway: targeting ERK to overcome obstacles to effective cancer therapy.Mortality in children with low-grade glioma or glioneuronal tumors: A single-institution study.Disseminated glioneuronal tumors occurring in childhood: treatment outcomes and BRAF alterations including V600E mutation.Pediatric low-grade gliomas: implications of the biologic era.Epigenetic repression of the dopamine receptor D4 in pediatric tumors of the central nervous system.
P2860
Q26766271-374835BD-873C-41DC-8C8F-FDC13B5F083BQ26864920-2DC79E17-E1FA-4A92-8EB3-DC57CAB5AD22Q27010414-524CABA7-5569-40E7-9431-5636E2642FBDQ28286218-6F234A2E-3F52-4D9B-8FE6-EF402325E2B7Q30855264-4AE85A2A-88D6-40C6-9D53-C93CD68EA7A0Q33610906-493FA748-2584-4057-AC7A-C5456F53580CQ33616609-66DEFAC0-6056-4379-8C60-038DE72B00A1Q33654483-9473282F-5B7D-4F35-9D0E-AB6D99A4EDABQ33685551-25E2CE0B-5AA6-42F9-8A2B-31947E193FDDQ34354839-090D0323-E12B-4417-9B3A-EBADB986A834Q34525316-39A15C7C-E6BD-4662-830A-398BCEA91C03Q34810518-5D5AA02D-C1FB-487F-A0CC-7CBB90DDC215Q34886859-EDFE604D-C180-4268-81F8-8A8F3E8A2EDDQ35184491-8709964B-69AC-49C3-81B9-931669C11444Q35388346-9D1C6946-220C-4186-BA08-6CD3AC50194DQ35751428-402DD0AC-782A-4A97-8725-4EE12DC44923Q35866716-6319F899-10DC-4C19-8F11-F56D520ED1DAQ35870174-1E1DD7C2-FD4C-4AD3-989C-AB90118E4715Q36009738-AADC2EFE-6792-492D-93F1-6EB266B74F23Q36344704-9E5B95FD-DD65-477B-8CAF-BF64412B7C79Q36500392-A9A38880-946E-4E59-8612-5245D9706B6DQ36544705-C4336936-9D63-45FE-84FD-FE7ABD17F717Q36873428-BF5E3436-9DC7-49AB-8B3E-FFE7ADF5B26FQ37198942-934F0F5E-963D-4FF1-BB2B-111170795238Q37213305-E4986AE9-C7BE-45E8-B071-1A7DAE563A0EQ37597227-C6EC3880-6097-4193-B0A2-D4C9371F9DA6Q37612660-B56B15D5-2109-4F24-8ABA-2D6658B6BD23Q37709935-AD8CA2C8-019E-43C6-B767-A20B9D03358BQ38050966-23B873E4-2809-41B1-A0B7-0E1DD23E36F3Q38107462-1093B56F-5A65-4F56-828D-FDF942D83A25Q38125816-490C2848-2D29-415E-A614-9251E3DB8A9CQ38203283-77BACF18-64D8-4E3C-B185-A6B772252D57Q38231122-7BBD25DD-759C-4854-A74A-F84E3306F834Q38288352-BB812EE9-A46C-4506-B68C-81C5E2B8D74EQ38315617-0E7BBA31-C4FD-485C-9B1F-E4DD594B4D06Q38397326-73BE18FE-12DD-4A96-BB23-DC1E6E503E63Q38679142-902BC55D-A9D3-4177-90ED-9060C83DCE60Q38781649-AA94D76C-58DB-484E-913A-0DC1503A9531Q38816560-29BD19C2-8EC1-412F-A9E1-3082D475084BQ39058741-5E41A668-5077-4B77-96EB-847AC016A82A
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
MAPK pathway activation in pilocytic astrocytoma
@ast
MAPK pathway activation in pilocytic astrocytoma
@en
MAPK pathway activation in pilocytic astrocytoma
@nl
type
label
MAPK pathway activation in pilocytic astrocytoma
@ast
MAPK pathway activation in pilocytic astrocytoma
@en
MAPK pathway activation in pilocytic astrocytoma
@nl
prefLabel
MAPK pathway activation in pilocytic astrocytoma
@ast
MAPK pathway activation in pilocytic astrocytoma
@en
MAPK pathway activation in pilocytic astrocytoma
@nl
P2860
P50
P3181
P1476
MAPK pathway activation in pilocytic astrocytoma
@en
P2093
Jan Gronych
P2860
P2888
P304
P3181
P356
10.1007/S00018-011-0898-9
P407
P577
2011-12-13T00:00:00Z
P5875
P6179
1037922098